Article PDF first page preview

First page of Serological evidence of bluetongue virus serotypes circulating in Pakistan

Introduction Bluetongue is an arthropod-borne viral disease of ruminants, which is caused by bluetongue virus (BTV) that exists in more than 30 different serotypes. The disease is endemic in Pakistan. However, little is known about circulating BTV serotypes in the country. This study reports the serotypes of BTV in North-Western Pakistan. Methods A total of 758 competitive ELISA positive serum samples was tested using serum neutralization tests against the 28 BTV serotypes (BTV-1 to 27 and BTV-X). The test samples originated from cattle (n = 296), buffalo (n = 80), sheep (n= 136) and goats (n= 246). Results Neutralizing antibodies against one or more of the 28 BTV serotypes were detected in 59.1% of the positive samples. Antibodies against BTV-26 had the highest (56.5%) prevalence, whereas, those against BTV-19 had the lowest (0.9%) prevalence. Species-wise, neutralizing antibodies against all the 28 serotypes of BTV were found in cattle, whereas antibodies against 24, 21 and 19 different serotypes of BTV were detected in goats, sheep and buffalo, respectively. Neutralizing antibodies against 19 different BTV serotypes were detected for the first time in Pakistan. It was also the first time that neutralizing antibodies against atypical serotypes (i.e. BTV-25, BTV-27, and BTV-X) were found in cattle. Conclusion Bluetongue in Pakistan has a complex epidemiology, as evidenced by the detection of antibodies against a large number of BTV serotypes Findings of the current study may be helpful in selecting appropriate vaccines for control of the disease in the country.

Journal Section:
Research Article
This content is only available via PDF.
The Author(s). Published by S. Karger AG, Basel
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .
Attribution-NonCommercial